September 10, 2019 News by Steve Bryson, PhD SPMS Triggers and Treatments Among Focus of Expert Panel in Video Series by AJMC Multiple sclerosis (MS) experts discuss disease causes and current treatment options in a new video series released by the multimedia and peer-reviewed science journal,Ā The American Journal of Managed Care (AJMC).Ā The free and online video series is part…
September 4, 2019 News by Steve Bryson, PhD MS Relationships Improved by Togetherness and Communication, Study Suggests Relationships between multiple sclerosis patients and their intimate partners were enhanced when the couple worked together to make lifestyle changes, and to develop skills to improve communication, a study shows.Ā
August 2, 2019 News by Steve Bryson, PhD Rewind Therapeutics Receives Research Grant to Develop New Remyelination Medicines for MS The development of new medicines to treat myelin-related neurological diseases, such as multiple sclerosis (MS), has been given a boost by a ā¬2.9 million (about $3.2 million) research grant awarded to the Belgian biotech company Rewind Therapeutics by…
July 31, 2019 News by Steve Bryson, PhD Surgery with Anesthesia Does Not Raise Person’s Risk of MS Relapse, Study Finds No excessive relapse risk appears to exist for people with multiple sclerosisĀ who undergo surgery that requires anesthesia, researchers report, challenging long-held assumptions associated with MS and surgery. Their single-site study, āMultiple sclerosis relapse risk in the postoperative period: Effects of…
July 30, 2019 News by Steve Bryson, PhD Early MRI Screening Can Predict Long-term MS Disability, Help Guide Treatment, Study Says Routine screening throughĀ magnetic resonance imaging (MRI) of people with multiple sclerosis (MS) can predict long-term disease progression ā leading to more certainty and informing better treatment choices, a 15-year study reported. The study, titled āEarly imaging predictors of long-term…
July 25, 2019 News by Steve Bryson, PhD Tecfidera Up Against Bafiertam in Phase 1 Study of GI Tolerability A first healthy volunteer has enrolled in a randomized, double-blind Phase 1 study to compare the gastrointestinal (GI) tolerability and safety of oral Tecfidera to Bafiertam, an oralĀ bioequivalent in treating relapsing forms of multiple sclerosis (MS),Ā Banner Life Sciences…
July 24, 2019 News by Steve Bryson, PhD Standing Frame Exercises Aid Lower Limbs of Progressive MS Patients, UK Study Says People whose advanced progressive multiple sclerosis (MS) limits their mobility can strengthen their lower limbs and improve life quality by engaging in regular standing exercises in their homes, a U.K. study into physiotherapy programs for this patient group reports. The study,Ā “Assessment…